Usefulness of the MPB-INFURG-SEMES model to predict bacteremia in the patient with solid tumor in the Emergency Department
CONCLUSIONS: The MPB-INFURG-SEMES score is useful for predicting bacteremia in the adults patients with solid tumor seen in the ED.PMID:38520173 | DOI:10.37201/req/004.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - March 23, 2024 Category: Drugs & Pharmacology Authors: M Muelas Gonz ález E Torner Marchesi G Pel áez Díaz M Ramos Aranguez J Caba ñas Morafraile W L ópez Forero R Rubio D íaz J Gonz ález Del Castillo F J Candel I Sanz-Mu ñoz grupo INFURG-SEMES (grupo de estudio de infecciones de la Sociedad Espa ñol Source Type: research
Usefulness of the MPB-INFURG-SEMES model to predict bacteremia in the patient with solid tumor in the Emergency Department
CONCLUSIONS: The MPB-INFURG-SEMES score is useful for predicting bacteremia in the adults patients with solid tumor seen in the ED.PMID:38520173 | DOI:10.37201/req/004.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - March 23, 2024 Category: Drugs & Pharmacology Authors: M Muelas Gonz ález E Torner Marchesi G Pel áez Díaz M Ramos Aranguez J Caba ñas Morafraile W L ópez Forero R Rubio D íaz J Gonz ález Del Castillo F J Candel I Sanz-Mu ñoz grupo INFURG-SEMES (grupo de estudio de infecciones de la Sociedad Espa ñol Source Type: research
Usefulness of the MPB-INFURG-SEMES model to predict bacteremia in the patient with solid tumor in the Emergency Department
CONCLUSIONS: The MPB-INFURG-SEMES score is useful for predicting bacteremia in the adults patients with solid tumor seen in the ED.PMID:38520173 | DOI:10.37201/req/004.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - March 23, 2024 Category: Drugs & Pharmacology Authors: M Muelas Gonz ález E Torner Marchesi G Pel áez Díaz M Ramos Aranguez J Caba ñas Morafraile W L ópez Forero R Rubio D íaz J Gonz ález Del Castillo F J Candel I Sanz-Mu ñoz grupo INFURG-SEMES (grupo de estudio de infecciones de la Sociedad Espa ñol Source Type: research
Microbiological and epidemiological features of respiratory syncytial virus
Rev Esp Quimioter. 2024 Mar 21:sanz21mar2024. doi: 10.37201/req/006.2024. Online ahead of print.ABSTRACTThe properties of the main surface proteins and the viral cycle of the respiratory syncytial virus (RSV) make it an attractive pathogen from the perspective of microbiology. The virus gets its name from the manner it infects cells, which enables it to produce syncytia, which allow the virus' genetic material to move across cells without having to release viral offspring to the cellular exterior, reducing immune system identification. This causes a disease with a high impact in both children and adults over 60, which has ...
Source: Revista Espanola de Quimioterapia - March 22, 2024 Category: Drugs & Pharmacology Authors: I Sanz-Mu ñoz L S ánchez-de Prada J Castrodeza-Sanz J M Eiros Source Type: research
Meningococcal meningitis in Spain in the Horizon 2030: A position paper
Rev Esp Quimioter. 2024 Mar 22:moraga22mar2024. doi: 10.37201/req/023.2024. Online ahead of print.ABSTRACTMeningococcal meningitis (MM) and invasive meningococcal disease remain a major public health problem that generates enormous public alarm. It is caused by Neisseria meningitidis, a Gram-negative diplococcus with an enormous capacity for acute and rapidly progressive disease, both episodic and epidemic in nature, with early diagnosis and treatment playing a major role. It occurs at any age, but is most common in children under 5 years of age followed by adolescents. Although most cases occur in healthy people, the inci...
Source: Revista Espanola de Quimioterapia - March 22, 2024 Category: Drugs & Pharmacology Authors: F Moraga-Llop E Andradas L C Blesa-Baviera R Cant ón J Gonz ález Del Castillo F Martin ón-Torres E Moya A Trilla J Vazquez R J Villena J Ruiz-Galiana P De Lucas Ramos A Garc ía-Botella A Garc ía-Lledó T Hern ández-Sampelayo J G ómez-Pavón M C Mar Source Type: research
Microbiological and epidemiological features of respiratory syncytial virus
Rev Esp Quimioter. 2024 Mar 21:sanz21mar2024. doi: 10.37201/req/006.2024. Online ahead of print.ABSTRACTThe properties of the main surface proteins and the viral cycle of the respiratory syncytial virus (RSV) make it an attractive pathogen from the perspective of microbiology. The virus gets its name from the manner it infects cells, which enables it to produce syncytia, which allow the virus' genetic material to move across cells without having to release viral offspring to the cellular exterior, reducing immune system identification. This causes a disease with a high impact in both children and adults over 60, which has ...
Source: Revista Espanola de Quimioterapia - March 22, 2024 Category: Drugs & Pharmacology Authors: I Sanz-Mu ñoz L S ánchez-de Prada J Castrodeza-Sanz J M Eiros Source Type: research
Meningococcal meningitis in Spain in the Horizon 2030: A position paper
Rev Esp Quimioter. 2024 Mar 22:moraga22mar2024. doi: 10.37201/req/023.2024. Online ahead of print.ABSTRACTMeningococcal meningitis (MM) and invasive meningococcal disease remain a major public health problem that generates enormous public alarm. It is caused by Neisseria meningitidis, a Gram-negative diplococcus with an enormous capacity for acute and rapidly progressive disease, both episodic and epidemic in nature, with early diagnosis and treatment playing a major role. It occurs at any age, but is most common in children under 5 years of age followed by adolescents. Although most cases occur in healthy people, the inci...
Source: Revista Espanola de Quimioterapia - March 22, 2024 Category: Drugs & Pharmacology Authors: F Moraga-Llop E Andradas L C Blesa-Baviera R Cant ón J Gonz ález Del Castillo F Martin ón-Torres E Moya A Trilla J Vazquez R J Villena J Ruiz-Galiana P De Lucas Ramos A Garc ía-Botella A Garc ía-Lledó T Hern ández-Sampelayo J G ómez-Pavón M C Mar Source Type: research
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rev Esp Quimioter. 2024 Mar 4:rodriguez04mar2024. doi: 10.37201/req/018.2024. Online ahead of print.ABSTRACTPneumonia is a multifaceted illness with a wide range of clinical manifestations, degree of severity and multiple potential causing microorganisms. Despite the intensive research of recent decades, community-acquired pneumonia remains the third-highest cause of mortality in developed countries and the first due to infections; and hospital-acquired pneumonia is the main cause of death from nosocomial infection in critically ill patients. Guidelines for management of this disease are available world wide, but there are...
Source: Revista Espanola de Quimioterapia - March 4, 2024 Category: Drugs & Pharmacology Authors: C M Rodr íguez-Leal C Gonz ález-Corralejo F J Candel M Salavert Medical societies for the 5th edition of Pneumonia Day Source Type: research
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rev Esp Quimioter. 2024 Mar 4:rodriguez04mar2024. doi: 10.37201/req/018.2024. Online ahead of print.ABSTRACTPneumonia is a multifaceted illness with a wide range of clinical manifestations, degree of severity and multiple potential causing microorganisms. Despite the intensive research of recent decades, community-acquired pneumonia remains the third-highest cause of mortality in developed countries and the first due to infections; and hospital-acquired pneumonia is the main cause of death from nosocomial infection in critically ill patients. Guidelines for management of this disease are available world wide, but there are...
Source: Revista Espanola de Quimioterapia - March 4, 2024 Category: Drugs & Pharmacology Authors: C M Rodr íguez-Leal C Gonz ález-Corralejo F J Candel M Salavert Medical societies for the 5th edition of Pneumonia Day Source Type: research
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rev Esp Quimioter. 2024 Mar 4:rodriguez04mar2024. doi: 10.37201/req/018.2024. Online ahead of print.ABSTRACTPneumonia is a multifaceted illness with a wide range of clinical manifestations, degree of severity and multiple potential causing microorganisms. Despite the intensive research of recent decades, community-acquired pneumonia remains the third-highest cause of mortality in developed countries and the first due to infections; and hospital-acquired pneumonia is the main cause of death from nosocomial infection in critically ill patients. Guidelines for management of this disease are available world wide, but there are...
Source: Revista Espanola de Quimioterapia - March 4, 2024 Category: Drugs & Pharmacology Authors: C M Rodr íguez-Leal C Gonz ález-Corralejo F J Candel M Salavert Medical societies for the 5th edition of Pneumonia Day Source Type: research
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rev Esp Quimioter. 2024 Mar 4:rodriguez04mar2024. doi: 10.37201/req/018.2024. Online ahead of print.ABSTRACTPneumonia is a multifaceted illness with a wide range of clinical manifestations, degree of severity and multiple potential causing microorganisms. Despite the intensive research of recent decades, community-acquired pneumonia remains the third-highest cause of mortality in developed countries and the first due to infections; and hospital-acquired pneumonia is the main cause of death from nosocomial infection in critically ill patients. Guidelines for management of this disease are available world wide, but there are...
Source: Revista Espanola de Quimioterapia - March 4, 2024 Category: Drugs & Pharmacology Authors: C M Rodr íguez-Leal C Gonz ález-Corralejo F J Candel M Salavert Medical societies for the 5th edition of Pneumonia Day Source Type: research
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rev Esp Quimioter. 2024 Mar 4:rodriguez04mar2024. doi: 10.37201/req/018.2024. Online ahead of print.ABSTRACTPneumonia is a multifaceted illness with a wide range of clinical manifestations, degree of severity and multiple potential causing microorganisms. Despite the intensive research of recent decades, community-acquired pneumonia remains the third-highest cause of mortality in developed countries and the first due to infections; and hospital-acquired pneumonia is the main cause of death from nosocomial infection in critically ill patients. Guidelines for management of this disease are available world wide, but there are...
Source: Revista Espanola de Quimioterapia - March 4, 2024 Category: Drugs & Pharmacology Authors: C M Rodr íguez-Leal C Gonz ález-Corralejo F J Candel M Salavert Medical societies for the 5th edition of Pneumonia Day Source Type: research
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rev Esp Quimioter. 2024 Mar 4:rodriguez04mar2024. doi: 10.37201/req/018.2024. Online ahead of print.ABSTRACTPneumonia is a multifaceted illness with a wide range of clinical manifestations, degree of severity and multiple potential causing microorganisms. Despite the intensive research of recent decades, community-acquired pneumonia remains the third-highest cause of mortality in developed countries and the first due to infections; and hospital-acquired pneumonia is the main cause of death from nosocomial infection in critically ill patients. Guidelines for management of this disease are available world wide, but there are...
Source: Revista Espanola de Quimioterapia - March 4, 2024 Category: Drugs & Pharmacology Authors: C M Rodr íguez-Leal C Gonz ález-Corralejo F J Candel M Salavert Medical societies for the 5th edition of Pneumonia Day Source Type: research
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rev Esp Quimioter. 2024 Mar 4:rodriguez04mar2024. doi: 10.37201/req/018.2024. Online ahead of print.ABSTRACTPneumonia is a multifaceted illness with a wide range of clinical manifestations, degree of severity and multiple potential causing microorganisms. Despite the intensive research of recent decades, community-acquired pneumonia remains the third-highest cause of mortality in developed countries and the first due to infections; and hospital-acquired pneumonia is the main cause of death from nosocomial infection in critically ill patients. Guidelines for management of this disease are available world wide, but there are...
Source: Revista Espanola de Quimioterapia - March 4, 2024 Category: Drugs & Pharmacology Authors: C M Rodr íguez-Leal C Gonz ález-Corralejo F J Candel M Salavert Medical societies for the 5th edition of Pneumonia Day Source Type: research
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rev Esp Quimioter. 2024 Mar 4:rodriguez04mar2024. doi: 10.37201/req/018.2024. Online ahead of print.ABSTRACTPneumonia is a multifaceted illness with a wide range of clinical manifestations, degree of severity and multiple potential causing microorganisms. Despite the intensive research of recent decades, community-acquired pneumonia remains the third-highest cause of mortality in developed countries and the first due to infections; and hospital-acquired pneumonia is the main cause of death from nosocomial infection in critically ill patients. Guidelines for management of this disease are available world wide, but there are...
Source: Revista Espanola de Quimioterapia - March 4, 2024 Category: Drugs & Pharmacology Authors: C M Rodr íguez-Leal C Gonz ález-Corralejo F J Candel M Salavert Medical societies for the 5th edition of Pneumonia Day Source Type: research
